Corneal collagen crosslinking in keratoconus and other eye disease

Keratoconus is a condition characterized by biomechanical instability of the cornea, presenting in a progressive, asymmetric and bilateral way. Corneal collagen crosslinking (CXL) with riboflavin and Ultraviolet-A (UVA) is a new technique of corneal tissue strengthening that combines the use of ribo...

Full description

Bibliographic Details
Main Authors: Adel Alhayek, Pei-Rong Lu
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2015-04-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.cn/en_publish/2015/2/20150235.pdf
_version_ 1818977419655118848
author Adel Alhayek
Pei-Rong Lu
author_facet Adel Alhayek
Pei-Rong Lu
author_sort Adel Alhayek
collection DOAJ
description Keratoconus is a condition characterized by biomechanical instability of the cornea, presenting in a progressive, asymmetric and bilateral way. Corneal collagen crosslinking (CXL) with riboflavin and Ultraviolet-A (UVA) is a new technique of corneal tissue strengthening that combines the use of riboflavin as a photo sensitizer and UVA irradiation. Studies showed that CXL was effective in halting the progression of keratoconus over a period of up to four years. The published studies also revealed a reduction of max K readings by more than 2 D, while the postoperative spherical equivalent (SEQ) was reduced by an average of more than 1 D and refractive cylinder decreased by about 1 D. The major indication for the use of CXL is to inhibit the progression of corneal ecstasies, such as keratoconus and pellucid marginal degeneration. CXL may also be effective in the treatment and prophylaxis of iatrogenic keratectasia, resulting from excessively aggressive photo ablation. This treatment has been used to treat infectious corneal ulcers with apparent favorable results. Most recent studies demonstrate the beneficial impact of CXL for iatrogenic ecstasies, pellucid marginal degeneration, infectious keratitis, bullous keratopathy and ulcerative keratitis. Several long-term and short-term complications of CXL have been studied and documented. The possibility of a secondary infection after the procedure exists because the patient is subject to epithelial debridement and the application of a soft contact lens. Formation of temporary corneal haze, permanent scars, endothelial damage, treatment failure, sterile infiltrates, bullous keratopathy and herpes reactivation are the other reported complications of this procedure.
first_indexed 2024-12-20T16:27:27Z
format Article
id doaj.art-4d56f93ecafe4b48acaa1bb8698b5377
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-12-20T16:27:27Z
publishDate 2015-04-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-4d56f93ecafe4b48acaa1bb8698b53772022-12-21T19:33:22ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982015-04-018240741810.3980/j.issn.2222-3959.2015.02.35Corneal collagen crosslinking in keratoconus and other eye diseaseAdel Alhayek0Pei-Rong Lu1Department of Ophthalmology, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, ChinaDepartment of Ophthalmology, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, ChinaKeratoconus is a condition characterized by biomechanical instability of the cornea, presenting in a progressive, asymmetric and bilateral way. Corneal collagen crosslinking (CXL) with riboflavin and Ultraviolet-A (UVA) is a new technique of corneal tissue strengthening that combines the use of riboflavin as a photo sensitizer and UVA irradiation. Studies showed that CXL was effective in halting the progression of keratoconus over a period of up to four years. The published studies also revealed a reduction of max K readings by more than 2 D, while the postoperative spherical equivalent (SEQ) was reduced by an average of more than 1 D and refractive cylinder decreased by about 1 D. The major indication for the use of CXL is to inhibit the progression of corneal ecstasies, such as keratoconus and pellucid marginal degeneration. CXL may also be effective in the treatment and prophylaxis of iatrogenic keratectasia, resulting from excessively aggressive photo ablation. This treatment has been used to treat infectious corneal ulcers with apparent favorable results. Most recent studies demonstrate the beneficial impact of CXL for iatrogenic ecstasies, pellucid marginal degeneration, infectious keratitis, bullous keratopathy and ulcerative keratitis. Several long-term and short-term complications of CXL have been studied and documented. The possibility of a secondary infection after the procedure exists because the patient is subject to epithelial debridement and the application of a soft contact lens. Formation of temporary corneal haze, permanent scars, endothelial damage, treatment failure, sterile infiltrates, bullous keratopathy and herpes reactivation are the other reported complications of this procedure.http://www.ijo.cn/en_publish/2015/2/20150235.pdfkeratoconuscollagencorneal cross-linkingultraviolet radiation and riboflavin
spellingShingle Adel Alhayek
Pei-Rong Lu
Corneal collagen crosslinking in keratoconus and other eye disease
International Journal of Ophthalmology
keratoconus
collagen
corneal cross-linking
ultraviolet radiation and riboflavin
title Corneal collagen crosslinking in keratoconus and other eye disease
title_full Corneal collagen crosslinking in keratoconus and other eye disease
title_fullStr Corneal collagen crosslinking in keratoconus and other eye disease
title_full_unstemmed Corneal collagen crosslinking in keratoconus and other eye disease
title_short Corneal collagen crosslinking in keratoconus and other eye disease
title_sort corneal collagen crosslinking in keratoconus and other eye disease
topic keratoconus
collagen
corneal cross-linking
ultraviolet radiation and riboflavin
url http://www.ijo.cn/en_publish/2015/2/20150235.pdf
work_keys_str_mv AT adelalhayek cornealcollagencrosslinkinginkeratoconusandothereyedisease
AT peironglu cornealcollagencrosslinkinginkeratoconusandothereyedisease